Precision Medicine in Saxony: a new industry sector is emerging

Dresden, 10.10.2023. Today, we had the privilege of hosting the Prime Minister of the Free State of Saxony, Mr. Michael Kretschmer. During the session, Wilhelm Zörgiebel and Norman Gerstner shared a captivating overview of the present advancements in molecular diagnostics and their crucial role in precision medicine.

The key messages:

With precision medicine, a new industry sector is emerging in Saxony and Saxon companies, clinics and research institutions are leading the way.
The companies of the MDG Group provide comprehensive solutions for highly specialized molecular diagnostics in precision medicine.
With MODAPLEX, BIOTYPE offers a diagnostic platform that simplifies laboratory and clinic operations while also allowing for very accurate assessments to be made about tailor-made treatments in a short period of time.
MODAPLEX is a technology allowing efficient integration of biomarker signature analysis into clinical routine, supporting lab professionals and clinicians in their daily work.
Last but not least, Dresden ranks among the top three locations in Germany for artificial intelligence and data expertise essential for modern diagnostic procedures, alongside Munich and the Stuttgart, Heidelberg and Tübingen regions.

Together with our partners qualitype GmbH, ROTOP Pharmaka GmbH, imk Health Intelligence, Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, biosaxony , we will continue to advance precision medicine with unwavering perseverance in the coming years.